← Open Payments lookup

SHYMOL JOHN: Open Payments

NPI 1679115703 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,473 in 250 payments from 21 companies in 2025. Trend: 2023 $1,731 · 2024 $3,740 · 2025 $7,473

Food & beverage: $4,783Speaker / faculty: $2,640Education: $51
CompanyPaymentsAmount
Intercept Pharmaceuticals, Inc.8$2,751
ABBVIE INC.64$1,345
Madrigal Pharmaceuticals22$717
Janssen Biotech, Inc.38$529
Salix Pharmaceuticals, a division of Bausch Health US, LLC19$297
Ipsen Biopharmaceuticals, Inc14$223
GENZYME CORPORATION12$202
Takeda Pharmaceuticals U.S.A., Inc.11$192
Regeneron Healthcare Solutions, Inc.7$183
Lilly USA, LLC7$180

Products named: OCALIVA, REZDIFFRA, TREMFYA, RINVOQ, DUPIXENT, CREON, LINZESS, XIFAXAN.

Industry payments across OK — which companies pay providers there.